Press release
Arthritic Therapeutic Market Poised for 6.1% Growth, Set to Hit $91.7 Billion by 2029
Arthritic Therapeutic
The increasing prevalence of arthritis is expected to accelerate the growth of the arthritic therapeutic market. Arthritis encompasses over 100 conditions, mainly involving joint pain and inflammation. The rising incidence of arthritis is attributed to an aging population, higher obesity rates, and lifestyle factors contributing to joint stress. Treatments for arthritis aim to alleviate symptoms, reduce inflammation, and improve joint function, enhancing the overall quality of life for patients. For instance, in June 2024, the Australian Institute of Health and Welfare reported that around 514,000 people in Australia were living with rheumatoid arthritis in 2022, representing 2.0% of the population. This rise in arthritis cases is fueling the growth of the arthritic therapeutic market.
Get Your Arthritic Therapeutic Market Report Here:
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report
What is the future CAGR of the arthritic therapeutic market, and how will it impact industry expansion?
The arthritic therapeutic market has shown strong growth in recent years. It is expected to rise from $68.1 billion in 2024 to $72.44 billion in 2025, with a CAGR of 6.4%. This growth in the past can be credited to an increasing number of diagnosed patients, greater awareness of symptoms, a higher prevalence of obesity, improved diagnostic capabilities, and advancements in treatment outcomes.
The arthritic therapeutic market is anticipated to witness robust growth over the next few years, reaching $91.72 billion by 2029 at a CAGR of 6.1%. This growth can be attributed to enhanced healthcare infrastructure, supportive government initiatives, favorable regulatory policies, a growing focus on personalized medicine, and a shift toward patient-centric healthcare models. Major trends expected in the forecast period include an increased focus on biosimilars, a transition toward biologics, greater availability of biosimilars, a preference for parenteral administration, and the expansion of online pharmacies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp
What are the most significant trends transforming the arthritic therapeutic market today?
In the arthritis therapeutic market, companies are focusing on biosimilar monoclonal antibody-based therapies to enhance treatment efficacy and reduce costs. A notable example is Bio-Thera Solutions Ltd., which launched TOFIDENCE, a biosimilar monoclonal antibody for treating rheumatoid arthritis and related conditions. This development allows patients to access more affordable treatments that replicate the therapeutic benefits of the original monoclonal antibody, ACTEMRA, offering a lower-cost alternative with similar effectiveness.
Which key market segments comprise the arthritic therapeutic market and drive its revenue growth?
The arthritic therapeuticmarket covered in this report is segmented -
1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297
What regions are at the forefront of arthritic therapeutic market expansion?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the arthritic therapeutic market?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp
What Is Covered In The Arthritic Therapeutic Global Market Report?
•Market Size Forecast: Examine the arthritic therapeutic market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the arthritic therapeutic market for a structured understanding.
•Key Players Overview: Analyze major players in the arthritic therapeutic market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the arthritic therapeutic market.
•Segment Contributions: Evaluate how different segments drive overall growth in the arthritic therapeutic market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the arthritic therapeutic market.
•Industry Challenges: Identify potential risks and obstacles affecting the arthritic therapeutic market.
•Competitive Landscape: Review strategic developments in the arthritic therapeutic market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Arthritic Therapeutic Market Poised for 6.1% Growth, Set to Hit $91.7 Billion by 2029 here
News-ID: 3941126 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Inhibitors
Thymidine Phosphorylase Inhibitors Market - Breaking the Cycle: Angiogenesis Inh …
Newark, New Castle, USA: The "Thymidine Phosphorylase Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Thymidine Phosphorylase Inhibitors Market: https://www.growthplusreports.com/report/thymidine-phosphorylase-inhibitors-market/8826
This latest report researches the industry structure,…
CGRP Inhibitors Market - Break Free from Migraine: CGRP Inhibitors Redefining Re …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global CGRP Inhibitors Market.
CGRP Inhibitors Market: https://www.growthplusreports.com/report/cgrp-inhibitors-market/9155
The CGRP Inhibitors Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
